Quantity vs. Frequency - One of the most significant distinctions between medical and recreational cannabis users lies in their purchasing patterns specifically, the quantity of product purchased per transaction versus the frequency of purchases.
According to fresh data from the US National Institute on Drug Abuse, young women have officially overtaken men in cannabis consumption rates for the first time in recorded history. That's right – the ladies are officially out-toking the gents, at least in the 19-30 age bracket. And let me tell you, this isn't just some statistical blip – it's a seismic shift that's already sending ripples through the industry.
Many states have enacted strict privacy laws that prevent dispensaries from sharing customer data without explicit consent. For instance, in California, personal data collected by dispensaries is generally prohibited from being shared without customer approval.
Flower reigns supreme, whether buying it as buds and flowers or having those buds and flowers pre-rolled into joints for you, smoking cannabis is still the king according to a new industry study! With customer tastes changing toward convenience and ready-to-use products, pre-rolled joints have transformed from a niche product to a retail mainstay, quickly becoming one of the cannabis industry's fastest-growing segments.
However, psilocybin or magic mushrooms have been promising for the treatment of alcohol use disorder. Recent studies have shed light on the therapeutic benefits of psilocybin for alcoholism, specifically its efficacy and quick-acting mechanisms. A recent study conducted by investigators at the University of Copenhagen together with the National Institute on Alcohol Abuse and Alcoholism revealed that just one dose of psilocybin taken from magic mushrooms was successful in treating alcohol use disorder (AUD).
In a significant move aimed at regulating the burgeoning cannabis industry in New York, Attorney General Letitia James has announced a substantial penalty against George West, the owner of the unlicensed cannabis shop Jaydega 7.0 located in Canandaigua. The judgment, which totals $9.5 million, underscores the state’s commitment to enforcing its cannabis laws and ensuring that operators comply with legal standards.
The conversation around cannabis legalization is heating up in Kansas. Recently, Debbi Beavers, a top state official, suggested that it might be “easier” for lawmakers to legalize recreational marijuana rather than starting with a medical cannabis program. This statement has ignited discussions about the implications of such a shift in policy.
But what if I told you that the most dangerous drug isn't what you think it is? If you stopped random people on the street and asked them to name the most harmful substance, you'd likely hear responses like "heroin," "crack," or "meth." However, a fascinating study by Professor David Nutt and his colleagues reveals a far different reality.
Researchers at the Centre for Psychedelic Research at Imperial College in London found that taking magic mushrooms were more successful at treating depression compared to the widely prescribed SSRI antidepressants. For the study, they focused on escitalopram, an SSRI antidepressant, and psilocybin.
Now, here's where it gets interesting. Of these 117,130 pregnant individuals, 4.6% screened positive for cannabis use during early pregnancy. That's about 5,388 cannabis-using moms-to-be, if my back-of-the-rolling-paper math is correct. So, what did they find? Hold onto your hats, because this might blow your mind: maternal prenatal cannabis use was not associated with an increased risk of offspring developing ADHD or disruptive behavior disorders (DBD). In fact, the adjusted hazard ratio for ADHD was 0.84, which is science-speak for "Nope, no link here."
